RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.

Add to Collection
2010 Sep Others Fist_Author_Year_PM

Full Author : ['Schwartz, Eric A', 'Koska, Juraj', 'Mullin, Michael P', 'Syoufi, Iyad', 'Schwenke, Dawn C', 'Reaven, Peter D']
Journal Title : Atherosclerosis
Chapter : Section3
Journal Year : 2010
Cited by : Not Available

OBJECTIVE: Chronic exenatide treatment in type 2 diabetes is associated with improved glucose control and fasting lipid levels, as well as weight loss. Less established is whether exenatide directly reduces postprandial lipid and lipoprotein levels withou.....

Keywords : ["recent onset type diabetes mellitus", "exenatide suppress postprandial elevation", "impair glucose tolerance", "lipoprotein", "lipid", "individual"]